参考文献のリスト
|
1) Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation
of prochlorperazine versus metoclopramide for emergency department treatment
of migraine headache. Ann Emerg Med. 1995; 26(5): 541-6.
2) Jones J, Pack S, Chun E. Intramuscular prochlorperazine versus
metoclopramide as single-agent therapy for the treatment of acute migraine
headache. Am J Emerg Med. 1996; 14(3): 262-4.
3) Jones EB, Gonzalez ER, Boggs JG, Grillo JA, Elswick RK Jr. Safety and efficacy
of rectal prochlorperazine for the treatment of migraine in the emergency
department. Ann Emerg Med. 1994; 24(2): 237-41.
4) Di Monda V, Nicolodi M, Aloisio A, Del Bianco P, Fonzari M, Grazioli I, Uslenghi C,
Vecchiet L, Sicuteri F. Efficacy of a fixed combination of indomethacin,
prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple
migraine attacks: a multicenter, randomized, crossover trial. Headache. 2003;
43(8): 835-44.
5) Tanen DA, Miller S, French T, Riffenburgh RH. Intravenous sodium valproate
versus prochlorperazine for the emergency department treatment of acute
migraine headaches: a prospective, randomized, double-blind trial. Ann Emerg
Med. 2003; 41(6): 847-53.
6) Bigal ME, Bordini CA , Speciali JG. Intravenous chlorpromazine in the
emergency department treatment of migraines: a randomized controlled trial. J
Emerg Med. 2002; 23(2): 141-8.
7) Monzillo PH, Nemoto PH, Costa AR, Sanvito WL. [Acute treatment of migraine in
emergency room: comparative study between dexametasone and haloperidol.
Preliminary results] Arq Neuropsiquiatr. 2004; 62(2B):513-8. Epub 2004 Jul 20.
Portuguese.
8) Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective
placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide
in the management of acute migraine attacks in the Emergency Department.
Cephalalgia. 2005; 25(3): 199-204.
9) Blanda M, Rench T, Gerson LW, Weigand JV. Intranasal lidocaine for the
treatment of migraine headache: a randomized, controlled trial. Acad Emerg Med.
2001; 8(4): 337-42.
|